SEC Form 4 · accession 0000899243-19-006768
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James N Wilson
Director
Period of report
Feb 25, 2019
Accepted (ET)
Mar 7, 2019 · 8:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 25, 2019 | G | 13,628 | $0.00 | D | 1,331,574 | I | James N. Wilson and Pamela D. Wilson Trust |
| Common Stock | holding | — | — | — | 10,000 | D | ||
| Common StockF1 | holding | — | — | — | 901,067 | I | James and Pamela Wilson Family Partners |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.